Nicotinamide Mononucleotide: Exploration of Diverse Therapeutic Applications of a Potential Molecule

Nicotinamide mononucleotide (NMN) is a nucleotide that is most recognized for its role as an intermediate of nicotinamide adenine dinucleotide (NAD+) biosynthesis. Although the biosynthetic pathway of NMN varies between eukaryote and prokaryote, two pathways are mainly followed in case of eukaryotic...

Full description

Bibliographic Details
Main Authors: Saikat Kumar Poddar, Ali Ehsan Sifat, Sanjana Haque, Noor Ahmed Nahid, Sabiha Chowdhury, Imtias Mehedi
Format: Article
Language:English
Published: MDPI AG 2019-01-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/9/1/34
_version_ 1828846058645487616
author Saikat Kumar Poddar
Ali Ehsan Sifat
Sanjana Haque
Noor Ahmed Nahid
Sabiha Chowdhury
Imtias Mehedi
author_facet Saikat Kumar Poddar
Ali Ehsan Sifat
Sanjana Haque
Noor Ahmed Nahid
Sabiha Chowdhury
Imtias Mehedi
author_sort Saikat Kumar Poddar
collection DOAJ
description Nicotinamide mononucleotide (NMN) is a nucleotide that is most recognized for its role as an intermediate of nicotinamide adenine dinucleotide (NAD+) biosynthesis. Although the biosynthetic pathway of NMN varies between eukaryote and prokaryote, two pathways are mainly followed in case of eukaryotic human—one is through the salvage pathway using nicotinamide while the other follows phosphorylation of nicotinamide riboside. Due to the unavailability of a suitable transporter, NMN enters inside the mammalian cell in the form of nicotinamide riboside followed by its subsequent conversion to NMN and NAD+. This particular molecule has demonstrated several beneficial pharmacological activities in preclinical studies, which suggest its potential therapeutic use. Mostly mediated by its involvement in NAD+ biosynthesis, the pharmacological activities of NMN include its role in cellular biochemical functions, cardioprotection, diabetes, Alzheimer’s disease, and complications associated with obesity. The recent groundbreaking discovery of anti-ageing activities of this chemical moiety has added a valuable essence in the research involving this molecule. This review focuses on the biosynthesis of NMN in mammalian and prokaryotic cells and mechanism of absorption along with the reported pharmacological activities in murine model.
first_indexed 2024-12-12T21:41:30Z
format Article
id doaj.art-c9ad6f6e59104a6a9e3b9e3d6682f778
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-12-12T21:41:30Z
publishDate 2019-01-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-c9ad6f6e59104a6a9e3b9e3d6682f7782022-12-22T00:11:02ZengMDPI AGBiomolecules2218-273X2019-01-01913410.3390/biom9010034biom9010034Nicotinamide Mononucleotide: Exploration of Diverse Therapeutic Applications of a Potential MoleculeSaikat Kumar Poddar0Ali Ehsan Sifat1Sanjana Haque2Noor Ahmed Nahid3Sabiha Chowdhury4Imtias Mehedi5Department of Clinical Pharmacy and Pharmacology, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, BangladeshDepartment of Clinical Pharmacy and Pharmacology, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, BangladeshDepartment of Clinical Pharmacy and Pharmacology, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, BangladeshDepartment of Clinical Pharmacy and Pharmacology, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, BangladeshDepartment of Clinical Pharmacy and Pharmacology, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, BangladeshDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, BangladeshNicotinamide mononucleotide (NMN) is a nucleotide that is most recognized for its role as an intermediate of nicotinamide adenine dinucleotide (NAD+) biosynthesis. Although the biosynthetic pathway of NMN varies between eukaryote and prokaryote, two pathways are mainly followed in case of eukaryotic human—one is through the salvage pathway using nicotinamide while the other follows phosphorylation of nicotinamide riboside. Due to the unavailability of a suitable transporter, NMN enters inside the mammalian cell in the form of nicotinamide riboside followed by its subsequent conversion to NMN and NAD+. This particular molecule has demonstrated several beneficial pharmacological activities in preclinical studies, which suggest its potential therapeutic use. Mostly mediated by its involvement in NAD+ biosynthesis, the pharmacological activities of NMN include its role in cellular biochemical functions, cardioprotection, diabetes, Alzheimer’s disease, and complications associated with obesity. The recent groundbreaking discovery of anti-ageing activities of this chemical moiety has added a valuable essence in the research involving this molecule. This review focuses on the biosynthesis of NMN in mammalian and prokaryotic cells and mechanism of absorption along with the reported pharmacological activities in murine model.https://www.mdpi.com/2218-273X/9/1/34ageingAlzheimer’s diseasediabetesischemic preconditioningnicotinamide mononucleotideobesity
spellingShingle Saikat Kumar Poddar
Ali Ehsan Sifat
Sanjana Haque
Noor Ahmed Nahid
Sabiha Chowdhury
Imtias Mehedi
Nicotinamide Mononucleotide: Exploration of Diverse Therapeutic Applications of a Potential Molecule
Biomolecules
ageing
Alzheimer’s disease
diabetes
ischemic preconditioning
nicotinamide mononucleotide
obesity
title Nicotinamide Mononucleotide: Exploration of Diverse Therapeutic Applications of a Potential Molecule
title_full Nicotinamide Mononucleotide: Exploration of Diverse Therapeutic Applications of a Potential Molecule
title_fullStr Nicotinamide Mononucleotide: Exploration of Diverse Therapeutic Applications of a Potential Molecule
title_full_unstemmed Nicotinamide Mononucleotide: Exploration of Diverse Therapeutic Applications of a Potential Molecule
title_short Nicotinamide Mononucleotide: Exploration of Diverse Therapeutic Applications of a Potential Molecule
title_sort nicotinamide mononucleotide exploration of diverse therapeutic applications of a potential molecule
topic ageing
Alzheimer’s disease
diabetes
ischemic preconditioning
nicotinamide mononucleotide
obesity
url https://www.mdpi.com/2218-273X/9/1/34
work_keys_str_mv AT saikatkumarpoddar nicotinamidemononucleotideexplorationofdiversetherapeuticapplicationsofapotentialmolecule
AT aliehsansifat nicotinamidemononucleotideexplorationofdiversetherapeuticapplicationsofapotentialmolecule
AT sanjanahaque nicotinamidemononucleotideexplorationofdiversetherapeuticapplicationsofapotentialmolecule
AT noorahmednahid nicotinamidemononucleotideexplorationofdiversetherapeuticapplicationsofapotentialmolecule
AT sabihachowdhury nicotinamidemononucleotideexplorationofdiversetherapeuticapplicationsofapotentialmolecule
AT imtiasmehedi nicotinamidemononucleotideexplorationofdiversetherapeuticapplicationsofapotentialmolecule